Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Chemistry
Emerging Technology
Immunoassays
Molecular Diagnostics
Pathology & AI
Molecular Diagnostics: Page 6
US ambassador visits NGS laboratory in India
By
LabPulse.com staff writers
There is growing bilateral cooperation in cancer research, prevention, control, and management, where leaders said they looked forward to the launch of the India-U.S. Cancer Dialogue.
October 30, 2023
Software reduces DANGER of CRISPR-Cas9 by shedding light on off-target edits
By
Nick Paul Taylor
A new software can improve the safety and utility of CRISPR-Cas9 gene editing by detecting off-target changes and eliminating the need for reference genomes, according to a paper published in
Bioinformatics Advances
.
October 27, 2023
FDA to discuss phaseout enforcement discretion for LDTs
By
Liz Carey
In relation to its proposed medical device rule targeting laboratory developed tests (LDTs), the U.S. Food and Drug Administration (FDA) will hold a webinar Tuesday, October 31, at 1 p.m. EST.
October 26, 2023
Polygenic risk score tests donât meet expectations, U.K. study shows
By
Matt Limb
Polygenic risk scores âperform poorly in screening and prediction of common disease,â failing to identify nearly 90% of patients who develop disease, according to a U.K. study.
October 26, 2023
Pharma companies back project to create largest African ancestry genomics research database
By
Nick Paul Taylor
AstraZeneca, Novo Nordisk, Regeneron, and Roche have backed a project to create the largest African ancestry genomics research database.
October 25, 2023
Sanger Institute starts program to make biology as easy to engineer as software
By
Nick Paul Taylor
The Wellcome Sanger Institute has begun a research program to empower scientists to engineer biology as easily as software, electronics, and cars.
October 23, 2023
Sophia Genetics, AstraZeneca, Memorial Sloan Kettering to collaborate on cancer test access
By
LabPulse.com staff writers
Sophia Genetics is collaborating with Memorial Sloan Kettering (MSK) Cancer Center and AstraZeneca to expand MSK's genomic sequencing tests to a global scale, with the aim of by providing more inclusive access to cancer testing worldwide.
October 20, 2023
AMP publishes best-practice recommendations for ctDNA assays
By
LabPulse.com staff writers
The Association for Molecular Pathology (AMP) has published its best-practice recommendations for validating, reporting, and publishing clinical circulating tumor DNA (ctDNA) assays.
October 17, 2023
23andMe accused of ârecklessâ practices as data leak triggers class action lawsuit
By
Nick Paul Taylor
23andMe faces a class action lawsuit for allegedly failing to use âadequate and reasonable cyber-security proceduresâ that could have prevented a data leak.
October 16, 2023
WHO launches expert review panel for NTD diagnostics
By
LabPulse.com staff writers
The World Health Organization (WHO) has created a pilot scheme for an expert review panel for diagnostic products as part of its program for neglected tropical diseases (NTDs).
October 13, 2023
Researchers develop nanopore sequencing method for mapping disease biomarkers
By
Matt Limb
A nanopore sequencing method that can map dozens of biomarkers at the same time has the potential to transform testing for heart disease and other conditions, say researchers.
October 11, 2023
Researchers develop technique for onsite detection of SARS-CoV-2
By
LabPulse.com staff writers
Researchers have developed a portable laboratory device for rapid onsite detection of SARS-CoV-2 RNA which holds promise for scenarios in which there is no or limited access to testing laboratories.
October 10, 2023
Previous Page
Page 6 of 193
Next Page
